How to Help Your Patients Save Money on Midazolam: A Provider's Guide to Savings Programs

For many patients prescribed Nayzilam (midazolam nasal spray), the cost of this specialty medication can be a significant barrier to care — with retail prices reaching $800 per fill. While generic injectable midazolam is relatively affordable in hospital settings, the branded outpatient formulations present real financial challenges. This guide provides a comprehensive overview of every cost-reduction strategy available to your patients in 2026, so your practice can proactively address medication affordability during the prescribing encounter.

Understanding the Cost Landscape for Midazolam Formulations

The financial picture varies dramatically by formulation:

Generic injectable midazolam (1–5 mg/mL): Typically billed through the medical benefit as part of a hospital or procedural claim; patient out-of-pocket is determined by deductible and facility charges rather than the drug cost itself

Generic midazolam oral syrup (2 mg/mL): Pharmacy benefit; retail price approximately $65; discount cards may reduce to $30–$50 range

Nayzilam nasal spray: Pharmacy benefit; retail ~$800; with GoodRx ~$640; with UCB savings card, eligible patients may pay significantly less; with UCB PAP, uninsured/underinsured patients may receive at no cost

UCB Nayzilam Patient Savings Card: Who Is Eligible?

UCB offers a Patient Savings Card for Nayzilam that reduces out-of-pocket costs for eligible commercially insured patients. Here's what providers need to know:

Eligibility: Patients with commercial (private) insurance; Medicare, Medicaid, and government-insured patients are generally not eligible

Enrollment: Call 1-888-786-5879 or visit nayzilam.com/savings. Your office's medication coordinator can initiate enrollment at the time of prescribing.

Benefit: Eligible patients pay as little as $0 (terms and maximum benefit apply); UCB pays the remaining cost up to specified limits

UCB Patient Assistance Program: For Uninsured and Underinsured Patients

For patients without adequate insurance coverage, UCB operates a Patient Assistance Program (PAP) that provides Nayzilam at little or no cost to eligible individuals:

Who qualifies: Uninsured or underinsured patients meeting income criteria; specific thresholds vary — apply to determine eligibility

How to apply: Online at ucb-pap.enrollsource.com or by calling 1-888-786-5879; requires prescriber signature, income documentation, and insurance information

Processing time: Typically 2–4 weeks; bridge supply may be available in urgent cases through UCB's hub program

Navigating Insurance Prior Authorization for Nayzilam

Prior authorization (PA) is commonly required for Nayzilam by commercial insurers. A strong PA submission includes:

Documented diagnosis of epilepsy with seizure clusters (include EEG and neurology notes)

Documentation of frequency and severity of seizure clusters requiring rescue therapy

Statement of medical necessity: why Nayzilam (rather than a less expensive alternative) is appropriate for this patient

If step therapy is required: documentation of prior trial of Diastat or other rescue formulations and outcomes

If a PA is denied, appeal promptly. Denials of medically necessary rescue medications are frequently overturned on appeal, particularly with supporting clinical documentation. UCB's patient support team can provide PA support letters and appeal templates.

Discount Cards for Generic Midazolam Formulations

For generic midazolam injectable or oral syrup dispensed at retail pharmacies, prescription discount cards can provide significant savings:

GoodRx: Reduces Nayzilam to ~$640 (20% off retail); significant savings on generic injectable and oral syrup versions

SingleCare: Shows prices as low as $3.20 per 10 mg/2 mL vial for generic injectable midazolam; available at Walgreens, CVS, Walmart, Kroger, and 65,000+ pharmacies

NeedyMeds: Free drug discount card and database of patient assistance programs; useful for identifying additional resources

Practice Workflow Recommendations

To systematically support Nayzilam cost access for your patients:

Add a "Nayzilam cost support" step to your prescribing workflow — enroll in UCB savings card at time of first prescription

Designate a care coordinator or MA to handle PA submissions and follow up on denials

Keep UCB's provider support line available: 1-888-786-5879 (same line for prescribers and patients)

When patients report difficulty filling Nayzilam, refer them to medfinder.com/providers for rapid pharmacy location support

Document a backup rescue prescription for all Nayzilam patients in case of temporary access interruptions

For pharmacy access support, direct patients and staff to medfinder for Providers — it calls pharmacies to find which ones can fill the specific prescription, saving your staff time and ensuring patient safety.

Share with your patients: How to Save Money on Midazolam in 2026 — a patient-facing guide to coupons, savings cards, and assistance programs.